| Released | Contributor | Author | Title | Pages | Price |
| 21-Dec-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for DRUGS | 18 |
$49 |
| 21-Dec-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Detailed Valuation Report for ADLS | 13 |
$25 |
| 20-Dec-2009 | Wright Reports |
N/A
| Wright Investors Service Comprehensive Report for Advanced Life Sciences Holdings, Inc. | 40 |
$65 |
| 19-Dec-2009 | Standard & Poor's Quantitative Report |
N/A
| Advanced Life Science Hldg | 4 |
$25 |
| 18-Dec-2009 | Pechala's Reports | Lubomir Pechala | ADVANCED LIFE SCIENCES HOLDINGS INC (ADLS=US) 2-weeks forecast | 1 |
$10 |
| 17-Dec-2009 | Ford Investor Services, Inc. |
N/A
| Value Graph: ADVANCED LIFE SC -- ADLS | 1 |
$4 |
| 17-Dec-2009 | Ford Investor Services, Inc. |
N/A
| Industry Value Graph: ADLS , CXM , INHX , THLD -- DRUGS | 3 |
$4 |
| 14-Dec-2009 | Reuters Investment Profile |
N/A
| Advanced Life Sciences Holdings Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 |
$20 |
| 11-Dec-2009 | Pechala's Reports | Frantisek Pechala | ADVANCED LIFE SCIENCES HOLDINGS INC (ADLS=US) 12-months forecast | 1 |
$15 |
| 11-Nov-2009 | Thomson StreetEvents |
N/A
| ADLS - Event Transcript of Advanced Life Sciences Inc. conference call, Nov. 10, 2009 / 10:00am ET | 12 |
$75 |
0.48% Nasdaq 
0.003 (1.70%) 
Research Reports
